Evidence map›Paper›PMID 41219872›Full record

ArticleBMC public health2025

Appraisal of community-based interventions for hepatitis B in underserved populations using the quadruple aim of value-based medicine: a scoping review within the VH-COMSAVAC project.

Filippo Paoletti, Melissa D'Agostino, Egidio De Mattia, Andrea Adduci, Piergiorgio Salerno, Camila A Picchio, Aina Nicolàs, Delfina Boudou, Stefania Boccia, Jeffrey V Lazarus and 1 more

Abstract readScoping Review
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Filippo PaolettiCritical Pathways and Outcomes Evaluation Unit, Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Rome, Italy. filippopaoletti.an@gmail.com.
Melissa D'AgostinoCritical Pathways and Outcomes Evaluation Unit, Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Rome, Italy.
Egidio De MattiaCritical Pathways and Outcomes Evaluation Unit, Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Rome, Italy.
Andrea AdduciCritical Pathways and Outcomes Evaluation Unit, Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Rome, Italy.
Piergiorgio SalernoCritical Pathways and Outcomes Evaluation Unit, Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Rome, Italy.
Camila A PicchioBarcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
Aina NicolàsBarcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
Delfina BoudouBarcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
Stefania BocciaSection of Hygiene, University Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
Jeffrey V LazarusBarcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
Antonio Giulio De BelvisCritical Pathways and Outcomes Evaluation Unit, Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic viral hepatitis remains a critical public health concern, a key focus of WHO's 2030 elimination targets. High-risk populations, especially migrants often facing significant healthcare barriers, are disproportionately affected globally by this condition. Community-based interventions are crucial for enhancing access to screening, vaccination, and linkage to care. This scoping review, a foundational step within the EU co-funded VH-COMSAVAC project, identifies and analyses how these interventions map to the Quadruple Aim framework of value-based medicine.

methodsThis scoping review adhered to PRISMA-ScR guidelines. Five scientific databases (MEDLINE, Embase, GlobalHealth, Scopus, Web of Science) were systematically searched up to July 30, 2023. Titles and abstracts of studies focusing on community-based HBV interventions, primarily targeting migrants and refugees while also encompassing other underserved populations, were independently screened by five reviewers using the Rayyan platform. Data extraction was conducted using a structured Excel spreadsheet, mapping reported outcomes to the Quadruple Aim framework (patient experience, population health, cost reduction, care team wellbeing) and intervention types (prevention, linkage to care, treatment).

resultsOf 34 included publications, 94% (n = 32) focused on prevention, 29% (n = 10) on linkage to care, and 6% (n = 2) on treatment strategies. Patient experience was the most reported value domain (56%, n = 19 studies), followed by population health (50%, n = 17 studies). Cost reduction (9%, n = 3 studies) and care team wellbeing (3%, n = 1 study) were considerably less represented. Point-of-care (PoC) testing demonstrated significantly higher linkage to care (86% vs. 34% for venepuncture) and 76.5% lower costs (€12.7 vs. €54.0 per screened person). Screening uptake in targeted intervention groups (19.5%) was also significantly higher than in control groups (1.7%; p = 0.014). Major reported barriers included language (62%), cultural/religious issues (50%), and lack of knowledge (32%).

conclusionsThe review reveals a significant gap in the comprehensive, value-based evaluation of existing community-based interventions, with no established framework existing. The VH-COMSAVAC project seeks to bridge this by developing a value-based assessment tool, leveraging the Quadruple Aim, to systematically assess its prevention and linkage-to-care interventions and guide evidence-based optimization.

Indexed as

Community Health ServicesHepatitis BVulnerable PopulationsHealth Services AccessibilityHumansTransients and MigrantsCommunity careHepatitisHepatocarcinomaUnderserved populationsValue-based medicine

Identifiers

PMID41219872
PMCPMC12606988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.